Gamgee was founded by Paul Conyngham, Robert Quinn in 2026.

Who are Gamgee's investors?

Gamgee's investors include Y Combinator.

How much funding has Gamgee raised?

Gamgee has disclosed $4M raised across 1 round.

Where is Gamgee headquartered?

Gamgee is headquartered in Tampa, US.

Gamgee

YC S26

Tampa, US · Founded 2026 · 2 employees · 1 known investors

Find your way into Gamgee

113 people in our graph share verified history with the Gamgee team — schools, employers, funds. One of them is your warm intro.

Pablo Lagosunlockedknows Paul Conyngham · together at Woolworths Group (overlapped)

×10knows the team · via University of Canterbury

knows the team · via Aurecon

GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.

Also known as Gamgee Technologies

AI & Machine Learning Biotech Deep Tech Healthtech Genomics Oncology AIUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S26)

Gamgee was founded in 2026 by Paul Conyngham and Robert Quinn.

Paul Conyngham in 𝕏FounderPaul Conyngham co-founded Core Intelligence, which developed applied AI systems for startups and enterprise, and has worked on machine learning, data science, and electrical and computer systems engineering. He is founder of Gamgee Technologies, which develops personalized mRNA cancer vaccines.

Robert QuinnCo-founder

Board

Vinod KhoslaBoard director

Investors · 1

Y CombinatorSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 round · 2014

▶$4MraisedNov 2014 · 3 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Robert QuinnExecutive Officer, Director, Promoter
Vinod KhoslaDirector

Offering amount: $4M
Amount sold: $4M
First sale: Nov 2014
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

🔓The debate over open vs. closed AI - by Yaro Celisycoproductions.com · Aug 2026

Mobile patient engagement startup Gamgee raises $4M - MedCity Newsmedcitynews.com · Nov 2014

Gamgee raises another $4M for voice-enabled patient engagement platform | VentureBeatventurebeat.com · Nov 2014

Frequently asked questions

What does Gamgee do?: GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
Who founded Gamgee?: Gamgee was founded by Paul Conyngham, Robert Quinn in 2026.
Who are Gamgee's investors?: Gamgee's investors include Y Combinator.
How much funding has Gamgee raised?: Gamgee has disclosed $4M raised across 1 round.
Where is Gamgee headquartered?: Gamgee is headquartered in Tampa, US.